Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options.
Mediterr J Hematol Infect Dis
; 13(1): e2021016, 2021.
Article
in English
| MEDLINE | ID: covidwho-1145644
ABSTRACT
BACKGROUND:
Coronavirus disease 2019 (COVID-19) is mainly a respiratory tract disease and acute respiratory failure with diffuse microvascular pulmonary thrombosis are critical aspects of the morbidity and mortality of this new syndrome.PURPOSE:
The aim of our study was to investigate, in severe COVID-19 hospitalized patients, the P-selectin plasma concentration as a biomarker of endothelial dysfunction and platelet activation.METHODS:
46 patients with severe or critical SARS-CoV-2 infection were included in the study. Age-matched patients then were divided in those requiring admission to the intensive care unit (ICU, ICU cases) vs those not requiring ICU hospitalization (non-ICU cases). Blood samples of severe COVID-19 patients were collected at the time of hospital admission. The quantification of soluble P-selectin was performed by ELI, assay.RESULTS:
Our study showed a higher P-selectin plasma concentration in patients with Covid-19, regardless of ICU admission, compared to the normal reference values and compared to ten contextually sampled healthy donors (HD); (COVID-19) median 65.2 (IQRs 45.1-81.1) vs. HD 40.3 (IQRs 24.3-48.7), p=0023. Moreover, results showed a significant reduction of P-sele din after platelets removal in HD, in contrast, both ICU and non-ICU COVID-19 patients showed similar high levels of P-selectin with and without platelets.CONCLUSION:
Elevation of P-selectin suggests a central role of platelet endothelium interaction as part of the multifaced pathogenic mechanism of COVID-19 leading to the local activation of hemostatic system forming pulmonary thrombi. Further work is necessary to determine the therapeutic role of antiplatelets agents or of the anti P-selectin antibody Crizanlizumab.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Mediterr J Hematol Infect Dis
Year:
2021
Document Type:
Article
Affiliation country:
MJHID.2021.016
Similar
MEDLINE
...
LILACS
LIS